Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taiqi Peiyuan Wujian Granules is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital. It is specifically formulated for the treatment of Acquired Immunodeficiency Syndrome (AIDS) in patients classified under the "Qi and Yin deficiency" syndrome type according to TCM diagnostics. The granules are intended for use as an adjunctive therapy alongside standard antiretroviral therapy (ART) to enhance immune recovery and alleviate clinical symptoms associated with chronic HIV infection. As a complex herbal formulation, its therapeutic mechanism is believed to involve immunomodulation and the tonification of vital energy (Qi) and essence (Yin), supporting the body's internal balance and immune resilience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taiqi Peiyuan Wujian Granules.